Martek Biosciences Corporation
SEC Filings
| Filing |
Description |
Date Filed  |
Size |
|
| 8-K |
current report |
Mar 5, 2010 |
2.2 MB |
|
| 8-K |
current report |
Mar 2, 2010 |
92.4 KB |
|
| 4 |
siewert, cyrill |
Mar 1, 2010 |
20.0 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
13.0 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.8 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
13.0 KB |
|
| CT ORDER |
confidential treatment order |
Mar 1, 2010 |
12.9 KB |
|
| 3 |
siewert cyrill |
Feb 17, 2010 |
20.9 KB |
|
| 8-K |
current report |
Feb 17, 2010 |
43.9 KB |
|
| SC 13G/A |
amended statement of beneficial ownership |
Feb 12, 2010 |
8.4 KB |
|
| SC 13G/A |
amended statement of beneficial ownership |
Feb 9, 2010 |
14.7 KB |
|
| SC 13G |
statement of beneficial ownership |
Feb 5, 2010 |
22.0 KB |
|
| DEF 14A |
definitive proxy statement |
Feb 3, 2010 |
416.2 KB |
|
| SC 13G |
statement of beneficial ownership |
Jan 29, 2010 |
25.0 KB |
|
| 4/A |
nitze peter a |
Jan 27, 2010 |
20.8 KB |
|
|
|
= add filing to Briefcase
|
|
